Abstract

Patients with COVID-19 with severe respiratory disease may require non-invasive ventilation (NIV) devices, and selection should consider the greatest ability to reduce coronavirus-sized particles aerosolization. The objective of this study was to characterize the aerosolization of coronavirus-sized particles using different oxygen delivery systems.

Highlights

  • Patients with COVID-19 with severe respiratory disease may require non-invasive ventilation (NIV) devices, and selection should consider the greatest ability to reduce coronavirus-sized particles aerosolization

  • Tukey’s post-hoc test showed the SuperNO2VA with High-Efficiency Particulate Air Filter (HEPA) filter (N) and Non-Vented NIV (NV-NIV) Mask with single-limb circuit each had Fit Factor (FF) indicating significantly reduced particle aerosolization compared to all other devices (P

  • No significant FF differences occurred with the SuperNO2VA without HEPA filter (N), Non-Rebreather, and NV-NIV Mask with duallimb circuit (P=1.0)

Read more

Summary

Introduction

Patients with COVID-19 with severe respiratory disease may require non-invasive ventilation (NIV) devices, and selection should consider the greatest ability to reduce coronavirus-sized particles aerosolization. 71-79% require mechanical ventilation and mortality is between 50-61.5% [4,5,6]. Mortality increases to 81% [4]. The pathophysiology of severe respiratory disease in COVID-19 has been likened to a form of Acute Respiratory Distress Syndrome (ARDS) [1]. The mainstay treatment of ARDS revolves around increased inspired oxygen concentration (FiO2), high positive end-expiratory pressure (PEEP), and low-tidal volume ventilation [7]. With the high mortality rates among ventilated patients, it is important to look to non-invasive respiratory support devices capable of improving FiO2 and PEEP, in patients with mild-to-moderate disease. Three non-invasive ventilation (NIV) techniques may be useful for COVID-19: high-flow nasal

Objectives
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call